» Articles » PMID: 19411679

The Inability of a Bacteriophage to Infect Staphylococcus Aureus Does Not Prevent It from Specifically Delivering a Photosensitizer to the Bacterium Enabling Its Lethal Photosensitization

Overview
Date 2009 May 5
PMID 19411679
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: It has been demonstrated that the efficiency of lethal photosensitization can be improved by covalently binding photosensitizing agents to bacteriophage. In this study we have investigated whether a bacteriophage requires the capacity to infect the bacterium to enhance lethal photosensitization when linked to a photosensitizer.

Methods: Tin (IV) chlorin e6 (SnCe6) was conjugated to bacteriophage Phi11, a transducing phage that can infect Staphylococcus aureus NCTC 8325-4, but not epidemic methicillin-resistant S. aureus (EMRSA)-16. The conjugate and appropriate controls were incubated with these bacteria and either exposed to laser light at 632.8 nm or kept in the dark.

Results: The SnCe6/Phi11 conjugate achieved a statistically significant reduction in the number of viable bacteria of both 8325-4 and EMRSA-16 strains by 2.31 log(10) and 2.63 log(10), respectively. The conjugate could not however instigate lethal photosensitization of Escherichia coli. None of the other combinations of controls, such as an equivalent concentration of SnCe6 only, an equivalent titre of bacteriophage only or experiments conducted without laser light, yielded significant reductions in the number of viable bacteria recovered.

Conclusions: The inability of a bacteriophage to infect S. aureus does not prevent it from specifically delivering a photosensitizer to a bacterium enabling its lethal photosensitization.

Citing Articles

Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era.

Ling H, Lou X, Luo Q, He Z, Sun M, Sun J Acta Pharm Sin B. 2022; 12(12):4348-4364.

PMID: 36561998 PMC: 9764073. DOI: 10.1016/j.apsb.2022.05.007.


Targeted Antimicrobial Photodynamic Therapy of Biofilm-Embedded and Intracellular Staphylococci with a Phage Endolysin's Cell Binding Domain.

Bispo M, Santos S, Melo L, Azeredo J, van Dijl J Microbiol Spectr. 2022; 10(1):e0146621.

PMID: 35196798 PMC: 8865409. DOI: 10.1128/spectrum.01466-21.


A combination therapy of Phages and Antibiotics: Two is better than one.

Li X, He Y, Wang Z, Wei J, Hu T, Si J Int J Biol Sci. 2021; 17(13):3573-3582.

PMID: 34512166 PMC: 8416725. DOI: 10.7150/ijbs.60551.


Bacteriophages Against Pathogenic Bacteria and Possibilities for Future Application in Africa.

Kassa T Infect Drug Resist. 2021; 14:17-31.

PMID: 33442273 PMC: 7797301. DOI: 10.2147/IDR.S284331.


Phage Therapy in the Postantibiotic Era.

Gordillo Altamirano F, Barr J Clin Microbiol Rev. 2019; 32(2).

PMID: 30651225 PMC: 6431132. DOI: 10.1128/CMR.00066-18.